Compounds > dactinomycin

dactinomycin and Myoepithelial Tumor

dactinomycin has been researched along with Myoepithelial Tumor in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Shenoy, N1
Athanasian, E; Brady, MS; Busam, K; Fitzgerald, MJ1

Other Studies

2 other study(ies) available for dactinomycin and Myoepithelial Tumor

ArticleYear
Aggressive myoepithelial carcinoma with EWSR1-POU5F1 fusion highly responsive to Ewing sarcoma combination chemotherapy.
    Cancer, 2020, 12-15, Volume: 126, Issue:24

    Topics: Antineoplastic Combined Chemotherapy Protocols; Black or African American; Cyclophosphamide; Dactinomycin; Humans; Liver Neoplasms; Male; Myoepithelioma; Neoplasm Grading; Octamer Transcription Factor-3; Oncogene Proteins, Fusion; RNA-Binding Protein EWS; Sarcoma, Ewing; Tomography, X-Ray Computed; Treatment Outcome; Vincristine; Young Adult

2020
Myoepithelial carcinoma of the extremity: Response to isolated limb infusion.
    Journal of surgical oncology, 2015, Volume: 112, Issue:5

    Topics: Adult; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Cancer, Regional Perfusion; Dactinomycin; Extremities; Female; Humans; Infusions, Intravenous; Male; Melphalan; Myoepithelioma; Neoplasm Staging; Prognosis; Survival Rate

2015